Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01160024 methoxy mycolic acid 2-{1-hydroxy-18-[2-(17-methoxy-18-methylhexatriacontyl)cyclopropyl]octadecyl}tetracosanoic acid FA 83:1;O2 C83H164O4 1225.262963
LMFA07010716 2-Hexenoylcholine {2-[(2E)-hex-2-enoyloxy]ethyl}trimethylazanium C11H22NO2 200.165054
LMFA07070027 (9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine 3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 18:3;O C25H43NO5 437.314124
LMFA07070027 (9Z,12Z,15Z)-3-hydroxyoctadecatrienoylcarnitine 3-{[(9Z,12Z,15Z)-3-hydroxyoctadeca-9,12,15-trienoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 18:3;O C25H43NO5 437.314124
LMFA01030982 4-ene-Valproic acid 2-propylpent-4-enoic acid FA 8:1 C8H14O2 142.099380
LMFA01030982 4-ene-Valproic acid 2-propylpent-4-enoic acid FA 8:1 C8H14O2 142.099380
LMFA07050100 (1-hydroxycyclohexyl)acetyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 8:1;O C29H48N7O18P3S 907.198939
LMFA07050100 (1-hydroxycyclohexyl)acetyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 8:1;O C29H48N7O18P3S 907.198939
LMFA07050100 (1-hydroxycyclohexyl)acetyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 8:1;O C29H48N7O18P3S 907.198939
LMFA07050100 (1-hydroxycyclohexyl)acetyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 8:1;O C29H48N7O18P3S 907.198939
LMFA07050100 (1-hydroxycyclohexyl)acetyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(1-hydroxycyclohexyl)acetyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 8:1;O C29H48N7O18P3S 907.198939
LMFA01031125 5Z,9Z,21Z-hexacosatrienoic acid 5Z,9Z,21Z-hexacosatrienoic acid FA 26:3 C26H46O2 390.349781
LMFA07050176 2E-Dodecenoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 12:1 C33H56N7O17P3S 947.266624
LMFA07050176 2E-Dodecenoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 12:1 C33H56N7O17P3S 947.266624
LMFA07050176 2E-Dodecenoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 12:1 C33H56N7O17P3S 947.266624
LMFA07050176 2E-Dodecenoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 12:1 C33H56N7O17P3S 947.266624
LMFA07050176 2E-Dodecenoyl-CoA 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-dodec-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} CoA 12:1 C33H56N7O17P3S 947.266624
LMFA02000328 9Z,11Z,13Z,15Z-octadecatetraenoic acid 9Z,11Z,13Z,15Z-octadecatetraenoic acid FA 18:4 C18H28O2 276.208930
LMFA01030091 22-tricosenoic acid 22-tricosenoic acid FA 23:1 C23H44O2 352.334131
LMFA01050168 12-hydroxy-10-dodecenoic acid 12-hydroxy-10-dodecenoic acid FA 12:1;O C12H22O3 214.156895
LMFA01050168 12-hydroxy-10-dodecenoic acid 12-hydroxy-10-dodecenoic acid FA 12:1;O C12H22O3 214.156895
LMFA01031052 Methyl 7Z,11Z-Hexadecadienoate Methyl 7Z,11Z-Hexadecadienoate FA 17:2 C17H30O2 266.224581
LMFA01050550 3-Acetoxy-palmitic acid 3-Acetoxy-hexadecanoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01031060 9Z,11Z,14Z-Eicosatrienoic acid 9Z,11Z,14Z-Eicosatrienoic acid FA 20:3 C20H34O2 306.255881
LMFA01031057 3Z,5E,7E-Decatrienoic acid 3Z,5E,7E-Decatrienoic acid FA 10:3 C10H14O2 166.099380
LMFA01031048 9,11,13-Octadecatriynoic acid Octadecatri-9,11,13-ynoic acid FA 18:6 C18H24O2 272.177630
LMFA01170147 Asperitaconic acid B 9-acetoxy-3S-carboxy-2-methylidenenonanoic acid FA 13:3;O4 C13H20O6 272.125990
LMFA01031366 Euphormarginata acid A 10Z,12Z,15Z-octadecatrienoic acid FA 18:3 C18H30O2 278.224581
LMFA08020211 Linoleyl hydroxamic acid N-hydroxy-9Z,12Z-octadecadienamide NA 18:2;O C18H33NO2 295.251129
LMFA01160028 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid FA 57:1;O C57H112O3 844.861147
LMFA01160028 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid FA 57:1;O C57H112O3 844.861147
LMFA01160028 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid 2-eicosyl-3-hydroxy-heptatriaconta-16Z-enoic acid FA 57:1;O C57H112O3 844.861147
LMFA01160053 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid FA 71:0;O2 C71H142O4 1059.090812
LMFA01160053 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid FA 71:0;O2 C71H142O4 1059.090812
LMFA01160053 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid FA 71:0;O2 C71H142O4 1059.090812
LMFA01160053 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid 2-eicosyl-3-hydroxy-32-methoxy-33-methyl-nonatetracontanoic acid FA 71:0;O2 C71H142O4 1059.090812
LMFA01031137 Octadeca-9-en-12,14,16-triynoic acid (Z)-octadeca-9-en-12,14,16-triynoic acid FA 18:7 C18H22O2 270.161980
LMFA08020224 N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester C38H70N2O7 666.518304
LMFA08020224 N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester C38H70N2O7 666.518304
LMFA08020224 N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester N-(3R-(15-methyl-3-(13-methyl-tetradecanoyloxy)-hexadecanoyl)-glycyl)-L-serine methyl ester C38H70N2O7 666.518304
LMFA08020208 (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide N-isobutylundeca-2E,4E-dien-8,10-diynamide NA 15:6 C15H19NO 229.146664
LMFA08020208 (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide N-isobutylundeca-2E,4E-dien-8,10-diynamide NA 15:6 C15H19NO 229.146664
LMFA01160092 2-tetracosyl-3-hydroxy-40-oxo-41-methyl-heptapentacontanoic acid 2-tetracosyl-3-hydroxy-40-oxo-41-methyl-heptapentacontanoic acid FA 82:1;O2 C82H162O4 1211.247313
LMFA01050567 3R-hydroxymyristic acid methyl ester Methyl 3R-hydroxytetradecanoate FA 15:0;O C15H30O3 258.219496
LMFA01010019 Nonadecylic acid nonadecanoic acid FA 19:0 C19H38O2 298.287181
LMFA03040014 Lipoxin B5 5S,14R,15S-trihydroxyicosa-6E,8Z,10E,12E,17Z-pentaenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03040014 Lipoxin B5 5S,14R,15S-trihydroxyicosa-6E,8Z,10E,12E,17Z-pentaenoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA03120004 clavulone IV methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12] FA 25:8;O5 C25H34O7 446.230456
LMFA03120004 clavulone IV methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12] FA 25:8;O5 C25H34O7 446.230456
LMFA03120004 clavulone IV methyl 4R,12S-diacetoxy-9-oxo-5Z,7Z,10Z,13Z-prostatetraenoate-cyclo[8,12] FA 25:8;O5 C25H34O7 446.230456